Abstract：Objective To explore the application effect of Huachansu Tablets in chemotherapy for postoperative patients with colorectal cancer.Methods A total of 122 cases of postoperative patients with colorectal cancer treated in our hospital from January 2018 to January 2019 were selected as the research objects.They were divided into study group (Huachansu Tablets combined with XELOX regimen treatment) and control group (XELOX regimen treatment), 61 cases in each group.The quality of life (KPS) scores, carcinoembryonic antigen (CEA) levels before and after treatment,and the incidence of adverse reactions of patients were compared between the two groups.Results There was no significant difference in KPS score between the two groups before treatment (t=0.097, P＞0.05).After treatment, the KPS score of the study group was (82.64±6.47) points, which was higher than that of the control group of (76.41±5.47)points, the difference was statistically significant (t=5.743, P＜0.05).The CEA levels of the two groups before treatment had no statistically significant difference (t=0.043, P＞0.05), and the CEA of the study group after treatment was (2.78±0.66 ) μg/ml, which was lower than that of the control group of (3.97±1.33) μg/ml, the difference was statistically significant (t=6.260, P＜0.05).The total incidence of adverse reactions in the study group was lower than that in the control group, and the difference was statistically significant (P＜0.05).Conclusion The treatment of colorectal cancer patients undergoing chemotherapy with Huachansu Tablets combined with XELOX regimen can improve the quality of life and chemotherapy effect of patients, reduce adverse reactions, and have high clinical application value.
王明伟. 华蟾素片在结直肠癌术后患者化疗中的应用效果[J]. 中国当代医药, 2020, 27(22): 91-93.
WANG Ming-wei. Application effect of Huachansu Tablets in chemotherapy for postoperative patients with colorectal cancer. 中国当代医药, 2020, 27(22): 91-93.
京公网安备 11010502046607号